When did OrthoPediatrics report Q2 2025 earnings?

OrthoPediatrics (KIDS) reported Q2 2025 earnings on August 5, 2025 after market close.

What were OrthoPediatrics's Q2 2025 revenue and EPS?

OrthoPediatrics reported revenue of $61.1M and eps of $-0.11 for Q2 2025.

Did OrthoPediatrics beat estimates in Q2 2025?

Revenue missed the consensus estimate of $61.4M by $317.6K. EPS beat the consensus estimate of $-0.17 by $0.06.

How did OrthoPediatrics's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 15.7% from $52.8M a year earlier and eps grew 52.2% from $-0.23.

Where can I find OrthoPediatrics's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001425450-25-000096) directly on SEC EDGAR. The filing index links above go to sec.gov.

OrthoPediatrics KIDS Q2 2025 earnings

Reported August 5, 2025 · After market close

Revenue$61.1MMiss by $317.6K

EPS-$0.11Beat by $0.06

Revenue estimate$61.4M

EPS estimate-$0.17

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$68.2M

EPS estimate-$0.31

Financials

Q2 2025

Income statement

See full

Revenue$61.1M+15.7%

Gross profit$44.0M+7.9%

Operating income-$10.7M-88.1%

Net income-$7.1M-18.0%

EPS (diluted)-$0.30-15.4%

Balance sheet

See full

Cash & equivalents$46.6M+50.9%

Total debt$1.4M-90.3%

Total equity$355.5M-4.2%

Total assets$503.6M+16.9%

Cash flow

See full

Operating cash flow-$10.5M-71.7%

CapEx$3.4M-48.5%

Free cash flow-$13.9M-8.9%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$530.8M-19.1%

Enterprise value$485.56M-24.1%

P/S2.4×-1.3×

Profitability

See full

Gross margin71.5%-3.1pp

Operating margin-18.7%+3.8pp

Net margin-18.9%+8.9pp

FCF margin-17.1%-4.7pp

Returns & leverage

See full

Return on equity-11.5%+29.5pp

Debt / equity0×0.0×

Current ratio6.7×+1.8×

Segments

By product

See full

Trauma and deformity$41.7M+10.3%

Scoliosis$18.5M+35.4%

Sports medicine/other$905.0K-32.9%

Versus estimates

Revenue

Q1 2026$59.4MBeat by $1.1M Q4 2025$61.6MBeat by $1.4M Q3 2025$61.3MBeat by $2.0M

Q2 2025$61.1MMiss by $317.6K

Q1 2025$52.4MBeat by $728.1K Q4 2024$52.7MMiss by $317.0K

Diluted EPS

Q1 2026-$0.42Miss by $0.04 Q4 2025-$0.26Beat by $0.11 Q3 2025-$0.24Beat by $0.02

Q2 2025-$0.11Beat by $0.06

Q1 2025-$0.39Miss by $0.13 Q4 2024-$0.29Beat by $0.04

Ask the moment OrthoPediatrics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did OrthoPediatrics report Q2 2025 earnings?: OrthoPediatrics (KIDS) reported Q2 2025 earnings on August 5, 2025 after market close.
What were OrthoPediatrics's Q2 2025 revenue and EPS?: OrthoPediatrics reported revenue of $61.1M and eps of $-0.11 for Q2 2025.
Did OrthoPediatrics beat estimates in Q2 2025?: Revenue missed the consensus estimate of $61.4M by $317.6K. EPS beat the consensus estimate of $-0.17 by $0.06.
How did OrthoPediatrics's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 15.7% from $52.8M a year earlier and eps grew 52.2% from $-0.23.
Where can I find OrthoPediatrics's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001425450-25-000096) directly on SEC EDGAR. The filing index links above go to sec.gov.